JP2012533519A5 - - Google Patents

Download PDF

Info

Publication number
JP2012533519A5
JP2012533519A5 JP2012515517A JP2012515517A JP2012533519A5 JP 2012533519 A5 JP2012533519 A5 JP 2012533519A5 JP 2012515517 A JP2012515517 A JP 2012515517A JP 2012515517 A JP2012515517 A JP 2012515517A JP 2012533519 A5 JP2012533519 A5 JP 2012533519A5
Authority
JP
Japan
Prior art keywords
cell preparation
patient
cell
hematopoietic stem
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012515517A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012533519A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/058675 external-priority patent/WO2010146177A1/en
Publication of JP2012533519A publication Critical patent/JP2012533519A/ja
Publication of JP2012533519A5 publication Critical patent/JP2012533519A5/ja
Pending legal-status Critical Current

Links

JP2012515517A 2009-06-18 2010-06-18 骨髄細胞外マトリックス抽出物およびその治療上の使用 Pending JP2012533519A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21818209P 2009-06-18 2009-06-18
US61/218,182 2009-06-18
PCT/EP2010/058675 WO2010146177A1 (en) 2009-06-18 2010-06-18 Bone marrow extracellular matrix extract and therapeutic use thereof

Publications (2)

Publication Number Publication Date
JP2012533519A JP2012533519A (ja) 2012-12-27
JP2012533519A5 true JP2012533519A5 (enExample) 2013-05-30

Family

ID=42556414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012515517A Pending JP2012533519A (ja) 2009-06-18 2010-06-18 骨髄細胞外マトリックス抽出物およびその治療上の使用

Country Status (5)

Country Link
US (1) US20120065620A1 (enExample)
EP (1) EP2442837B1 (enExample)
JP (1) JP2012533519A (enExample)
CN (1) CN102802686A (enExample)
WO (1) WO2010146177A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105395570A (zh) * 2015-09-23 2016-03-16 广东颐养抗衰老研究院 一种用于治疗老年性白血病的组合物
EP3411475B1 (en) * 2016-02-06 2025-08-27 President and Fellows of Harvard College Recapitulating the hematopoietic niche to reconstitute immunity
CA3095142A1 (en) 2018-03-30 2019-10-03 University Of Rochester Bioengineered wharton's jelly derived extracellular matrix

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674750A (en) 1995-05-19 1997-10-07 T. Breeders Continuous selective clonogenic expansion of relatively undifferentiated cells
US5925567A (en) 1995-05-19 1999-07-20 T. Breeders, Inc. Selective expansion of target cell populations
IT1282207B1 (it) * 1995-11-20 1998-03-16 Fidia Advanced Biopolymers Srl Sistemi di coltura di cellule staminali di midollo osseo umano in matrici tridimensionali costituiti da esteri dell'acido ialuronico
ES2338405T3 (es) * 1999-02-04 2010-05-07 Pluristem Ltd. Metodo y aparato para mantenimiento y expasion de celulas madre hemopoyeticas y/o celulas progenitoras.
US20040151700A1 (en) * 2001-10-30 2004-08-05 Harlan David M. Ex-vivo rescue of transplantable hematopoietic stem cells following myeloablative injury
AU2004242091C1 (en) * 2003-05-07 2009-12-24 La Jolla Institute For Molecular Medicine Administration of hyaluronic acid to enhance the function of transplanted stem cells
US7326571B2 (en) 2003-07-17 2008-02-05 Boston Scientific Scimed, Inc. Decellularized bone marrow extracellular matrix
JP2005192521A (ja) * 2004-01-09 2005-07-21 Hiroko Sato 部分分解重合性タンパク質からなる造血幹細胞を含む未熟な血液細胞(hsc)の増殖促進用支持体およびその支持体を使用したhscの製造方法。
CN105168250B (zh) * 2004-10-25 2019-02-05 塞勒兰特治疗公司 增殖骨髓细胞群体的方法及其应用
AU2006311482B2 (en) * 2005-11-08 2011-08-25 Georgia Tech Research Corporation Acellularized biomaterial from embryonic stem cells
CN101421393B (zh) * 2006-02-14 2013-08-14 塞勒兰特治疗公司 提高造血干细胞植入的方法和组合物
CN101062428A (zh) * 2006-04-24 2007-10-31 中国人民解放军军事医学科学院野战输血研究所 一种组织工程化皮肤的构建方法与应用
WO2007148332A1 (en) * 2006-06-22 2007-12-27 Yeda Resaerch And Development Co. Ltd Catecholamine receptor modulation
DE102006060247A1 (de) * 2006-09-15 2008-03-27 Ossacur Ag Differenzierung von Stammzellen
WO2009072990A1 (en) * 2007-12-06 2009-06-11 Agency For Science, Technology And Research Method for extracellular matrix mediated differentiation and proliferation of stem cells
WO2009080794A1 (en) * 2007-12-21 2009-07-02 Mc2 Cell Aps Method for preparing cell-specific extracellular matrices

Similar Documents

Publication Publication Date Title
Dabrowska et al. Immunomodulatory and regenerative effects of mesenchymal stem cells and extracellular vesicles: therapeutic outlook for inflammatory and degenerative diseases
Ionescu et al. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action
EP2422797A3 (en) Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
WO2011150055A3 (en) Methods, substrates, and systems useful for cell seeding of medical grafts
Budgude et al. Mesenchymal stromal cell‐derived extracellular vesicles as cell‐free biologics for the ex vivo expansion of hematopoietic stem cells
NZ603913A (en) Method of engrafting cells from solid tissues
PT1718338E (pt) Composições e métodos de libertação direcionada de fármacos in vitro e in vivo por meio de minicélulas intactas derivadas de bactérias
WO2014186469A3 (en) Human application of engineered chimeric antigen receptor (car) t-cells
CO6761392A2 (es) Administración de proteínas a partir de microportadores de células madre
JP2019505585A5 (enExample)
WO2010082787A3 (ko) 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물
FI3901251T3 (fi) Munuaissolupopulaatioita ja niiden käyttötapoja
CR20230147A (es) Preparación y almacenamiento de formulaciones de rna liposomal adecuadas para terapia
HK1202809A1 (en) Mammalian fetal pulmonary cells and therapeutic use of same
MY164521A (en) Method of producing recombinant tat-hoxb4h protein for use as a stimulant of hematopoiesis in vivo
Liu et al. Permanently hypoxic cell culture yields rat bone marrow mesenchymal cells with higher therapeutic potential in the treatment of chronic myocardial infarction
BR0312365A (pt) Meio de cultura autólogo de células-mães progenitoras autólogas humanas, métodos para a preparação do mesmo e de uma composição de células-mães progenitoras autólogas humanas e para a obtenção de células-mães progenitoras musculares autólogas humanas, emprego de um meio de cultura autólogo de células-mães progenitoras autólogas humanas, procedimento para a obtenção de células-mães progenitoras musculares autólogas humanas e procedimento terapêutico de cardiomioplastia celular autóloga, composição enriquecida com células-mães progenitoras musculares autólogas humanas e composição farmacêutica
WO2010108058A3 (en) Small molecule inhibitors of dusp6 and uses therefor
JP2012533519A5 (enExample)
WO2011099783A3 (ko) 지방조직 유래 줄기세포 및 단핵구로부터 세포성장인자의 생산방법 및 그 이용
CA2526244A1 (en) Pharmaceutical combination of g-csf and plgf useful for blood stem cell mobilization
WO2010073126A3 (en) Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof
BR112015010256A2 (pt) meio para cultivar, preservar e administrar células regenerativas
WO2007139939A3 (en) Methods and compositions using immunomodulatory compounds in combination therapy
RU2007132041A (ru) Биотрансплантат, способ его получения, способ лечения хронических диффузных заболеваний печени и способ лечения цироза печени и портальной гипертензии